SEC Form 4 · accession 0001127602-17-009203
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James C Foster
Officer — Chairman, President and CEO · Director
Period of report
Feb 27, 2017
Accepted (ET)
Mar 1, 2017 · 3:34 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 27, 2017 | F | 2,301 | $88.05 | D | 381,730 | D | |
| Common Stock | Feb 28, 2017 | M | 20,071 | $59.41 | A | 401,801 | D | |
| Common Stock | Feb 28, 2017 | S | 100 | $86.95 | D | 401,701 | D | |
| Common Stock | Feb 28, 2017 | S | 100 | $86.98 | D | 401,601 | D | |
| Common Stock | Feb 28, 2017 | S | 100 | $86.99 | D | 401,501 | D | |
| Common Stock | Feb 28, 2017 | S | 100 | $87.00 | D | 401,401 | D | |
| Common Stock | Feb 28, 2017 | S | 102 | $87.02 | D | 401,299 | D | |
| Common Stock | Feb 28, 2017 | S | 216 | $87.03 | D | 401,083 | D | |
| Common Stock | Feb 28, 2017 | S | 100 | $87.045 | D | 400,983 | D | |
| Common Stock | Feb 28, 2017 | S | 220 | $87.05 | D | 400,763 | D | |
| Common Stock | Feb 28, 2017 | S | 80 | $87.055 | D | 400,683 | D | |
| Common Stock | Feb 28, 2017 | S | 200 | $87.07 | D | 400,483 | D | |
| Common Stock | Feb 28, 2017 | S | 392 | $87.08 | D | 400,091 | D | |
| Common Stock | Feb 28, 2017 | S | 500 | $87.09 | D | 399,591 | D | |
| Common Stock | Feb 28, 2017 | S | 100 | $87.095 | D | 399,491 | D | |
| Common Stock | Feb 28, 2017 | S | 500 | $87.10 | D | 398,991 | D | |
| Common Stock | Feb 28, 2017 | S | 100 | $87.105 | D | 398,891 | D | |
| Common Stock | Feb 28, 2017 | S | 400 | $87.11 | D | 398,491 | D | |
| Common Stock | Feb 28, 2017 | S | 200 | $87.115 | D | 398,291 | D | |
| Common Stock | Feb 28, 2017 | S | 300 | $87.12 | D | 397,991 | D | |
| Common Stock | Feb 28, 2017 | S | 100 | $87.13 | D | 397,891 | D | |
| Common Stock | Feb 28, 2017 | S | 300 | $87.14 | D | 397,591 | D | |
| Common Stock | Feb 28, 2017 | S | 100 | $87.145 | D | 397,491 | D | |
| Common Stock | Feb 28, 2017 | S | 400 | $87.15 | D | 397,091 | D | |
| Common Stock | Feb 28, 2017 | S | 100 | $87.155 | D | 396,991 | D | |
| Common Stock | Feb 28, 2017 | S | 100 | $87.16 | D | 396,891 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $59.41 | Feb 28, 2017 | M | 20,071 | D | Feb 28, 2015 | Feb 28, 2021 | Common Stock | 20,071 | 20,072 | D |
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.